Matrix and adhesion molecules in kidney pathology: Recent observations

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 4, 1997, Pages 357-364

  Bruijn, Jan A ^a   Kootstra, Carine J ^a   Sutmuller, Marjolein ^a   Van Vliet, Anita I ^a   Bergijk, Eline C ^a   De Heer, Emile ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031257693     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90034-2     Document Type: Review

References (100)

1. Lewis RM, Armstrong MYK, Abdre-Schwartz J, et al. Chronic allogeneic disease. I. Development of glomerulonephritis. J Exp Med 1968; 128:653-67.
2. Goldman M, Drfuet P, Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically induced autoimmunity. Immunol Today 1991;12:223-27.
3. Rozendaal L, Pals DT, Gleichmann E, Melief CJM. Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease. Clin Exp Immunol 1990;82:527-32.
4. Gleichmann E, Van Elven EH, Van der Veen JPW. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 1982; 12:152-9.
5. Bruijn JA, Elven EH, Hogendoorn PCW, et al. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol 1988;130:639-41.
6. Sutmuller M, Baelde JJ, de Heer E, Bruijn JA. T-cell receptor Vβ repertoire in murine chronic graft-versus-host disease [abstract]. J Am Soc Nephrol 1996;7:1722.
7. Sutmuller M, Baelde JJ, De Heer E, Bruijn JA. Mls-1 incompatible donor thymocytes downmodulate the development of murine chronic graft-versus-host disease [abstract]. J Am Soc Nephrol 1996;7:1721.
8. Bruijn JA, Hogendoorn PCW, Corver WE, et al. Pathogenesis of experimental lupus nephritis. A role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol 1990;79:115-22.
9. Bruijn JA, Van Leer EHG, Baelde HJJ, et al. Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab Invest 1990;63:350-9.
10. Prins FA, Bruijn JA, de Heer E. Applications in renal immunopathology of reflection contrast microscopy: A novel superior light microscopical technique. Kidney Int 1996;49:261-6.
11. Bruijn JA, Van Elven EH, Corver WE, et al. Genetics of experimental lupus nephritis: Non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease. Clin Exp Immunol 1989;76:284-9.
12. Treurniet RA, Bergijk EC, Baelde JJ, et al. Gender-related influences on the development of chronic graft-versus-host disease-induced experimental glomerulonephritis. Clin Exp Immunol 1993;91:442-8.
13. Sutmuller M, Ekstijn GL, Ouellette S, et al. Non-MHC genes determine the pathogenesis of lupus nephritis in H-2-identical mouse strains. Clin Exp Immunol 1996;106:265-72.
14. Bruijn JA, Hoedemaeker PJ, Fleuren GJ. Pathogenesis of anti-basement membrane glomerulopathy and immune-complex glomerulonephritis: Dichotomy dissolved. Lab Invest 1989;61:480-8.
15. Bruijn JA, Bergijk EC, de Heer E, et al. Induction and progression of experimental lupus nephritis: Exploration of a pathogenetic pathway. Kidney Int 1992;41:5-13.
16. de Heer E, Bruijn JA. Advantages and shortcomings of experimental models of immune-mediated glomerular and tubulo-interstitial diseases. Exp Nephrol 1996;4:193-200.
17. Kootstra CJ, Veninga A, Baelde JJ, et al. Monoclonal autoantibodies react with renal tubular epithelium, laminin, and DNA in experimental lupus nephritis [abstract]. J Am Soc Nephrol 1993;4:611.
18. Farquhar MG. Molecular analysis of the pathological auto-immune antigens of Heymann nephritis. Am J Pathol 1996; 148:1331-7.
19. Kerjaschki D. Molecular development of immune deposits and proteinuria in Heymann nephritis. Clin Invest 1993;71: 817-21.
20. de Heer E, Bruijn JA, Hoedemaeker PJ. Heymann nephritis revisited. New insights into the pathogenesis of experimental membranous glomerulonephritis. Clin Exp Immunol 1993;94:393-4.
21. 1 integrin on glomerular epithelial cells and inhibits adhesion and growth. Am J Physiol (Renal Fluid Electrolyte Physiol) 1992;262:F770-6.
22. 1 integrin receptors. Am J Pathol 1996;149:987-96.
23. Van Leer EHG, Bruijn JA, Prins FA, et al. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Lab Invest 1993;68:550-6.
24. Van Leer EHG, de Roo GM, Bruijn JA, et al. Synergistic effects of anti-gp300 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage. Exp Nephrol 1993;1:292-300.
25. Bruijn JA, de Heer E. Biology of disease. Adhesion molecules in renal diseases. Lab Invest 1995;72:387-94.
26. Bruijn JA, Oemar BS, Ehrich JHH, et al. Anti-basement membrane glomerulopathy in experimental trypanosomiasis. J Immunol 1987;139:2482-8.
27. Kootstra CJ, van der Giezen DM, Van Krieken JHJM, et al. Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies. Clin Exp Immunol 1997;108:324-32.
28. Bruijn JA, Dinklo NJCM. Distinct patterns of expression of intercellular adhesion molecule-1 in renal disease. Lab Invest 1993;69:329-35.
29. Muller GA, Markovic-Lipkovski J, Muller CA. Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol 1991;36:203-8.
30. Markovic-Lipkovski J, Muller CA, Risler T, et al. Mononuclear leukocytes, expression of HLA class I antigens and intercellular adhesion molecule-1 in focal segmental glomerulosclerosis. Nephron 1991;59:286-93.
31. Moolenaar W, Bruijn JA, Schrama E, et al. T-cell receptors and ICAM-1 expression in renal allografts during rejection. Transplant Int 1991;4:140-5.
32. Kanagawa K, Ishikura H, Takahashi C, et al. Identification of ICAM-1-positive cells in the nongrafted and transplanted rat kidney - An immunohistochemical and ultrastructural study. Transplantation 1991;52:1057-62.
33. Parra G, Romero M, Henriquez-LaRoche C, et al. Expression of adhesion molecules in poststreptococcal glomerulo-nephritis. Nephrol Dial Transplant 1994;9:1412-7.
34. Kootstra CJ, Sutmuller M, Baelde JJ, et al. Glomerular leukocyte infiltration correlates with development of glomerulosclerosis in experimental lupus nephritis [abstract]. J Am Soc Nephrol 1996;7:1758.
35. Bergijk EC, Munaut C, Baelde JJ, et al. A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol 1992;140:1147-56.
36. Bergijk EC, Baelde JJ, de Heer E, et al. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness. Exp Nephrol 1995;3:338-47.
37. Vleming LJ, Baelde JJ, Westendorp RGJ, et al. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 1995;44:211-9.
38. Vleming LJ, Baelde JJ, Westendorp RGJ, et al. The glomerular deposition of PAS-positive material correlates inversely with renal function in human kidney diseases. Clin Nephrol 1997;47:158-67.
39. Munaut C, Bergijk EC, Baelde JJ, et al. A molecular biologic study of extracellular matrix components during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Lab Invest 1992;67:580-7.
40. Bergijk EC, de Heer E, Hoedemaeker PJ, Bruijn JA. A reapparaisal of immune-mediated glomerulosclerosis. A review. Kidney Int 1996;49:605-11.
41. Kwan G, neugarten J, Sherman M, et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 1996;50:1173-9.
42. Miner JH, Sanes JR. Collagen IV α3, α4, and α5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches. J Cell Biol 1994; 127: 879-91.
43. Vanden Heuvel GB, Leardkamolkarn V, St John PL, Abrahamson DR. Carboxy terminal sequence and synthesis of rat kidney laminin gamma 1 chain. Kidney Int 1996:49:752-60.
44. Noakes PG, Miner JH, Gautam M, et al. The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1. Nature Genet 1995;10: 400-6.
45. Gharaee-Kermani M, Wiggins R, Wolber F, et al. Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol 1996; 148:961-7.
46. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990;4:1577-90.
47. Costigan M, Chambers DA, Boot-Handford RP. Collagen turnover in renal disease. Exp Nephrol 1995;3:114-21.
48. Bergijk EC, Baelde JJ, de Heer E, et al. Differential mRNA and protein expression of collagen type IV (Col IV) sub-chains in experimental glomerulosclerosis [abstract]. J Am Soc Nephrol 1995;6:891.
49. Kunico GS, Alvarez R, Li SR, et al. Transforming growth factor-β modulation of the α(IV) collagen gene in murine proximal tubular cells. Am J Physiol (Renal Fluid Electrolyte Physiol) 1996;271:F120-5.
50. Ceol M, Nerlich A, Baggio B, et al. Increased glomerular α1(IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 1996;74:484-95.
51. Sutmuller M, Bruijn JA, de Heer E. Collagen types VIII and X, two non-fibrillar, short-chain collagens. Structure hornologies, functions and involvement in pathology. Histol Histopathol 1997;12:557-66.
52. van Griensven M, Baelde JJ, Killen PD, et al. Sex steroid hormones alter collagen gene expression in murine lupus nephritis [abstract]. J Am Soc Nephrol 1996;7:1749
53. van Griensven M, Bergijk EC, Baelde JJ, et al. Differential effects of sex hormones on autoantibody production and proteinuria in chronic graft-versus-host disease-induced experimental lupus nephritis. Clin Exp Immunol 1997;107: 254-261.
54. Kim Y, Butkowski R, Burke B, et al. Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 1991;139:1381-8.
55. Minto AW, Fogel MA, Natori Y, et al. Expression of type I collagen mRNA in glomeruli of rats with passive Heymann nephritis. Kidney Int 1993;43:121-7.
56. Minto AWM, Killen PD, Funabiki K, et al. Increased abundance of α4 type IV collagen mRNA in passive Heymann nephritis. Role of complement [abstract]. J Am Soc Nephrol 1995;6:901.
57. Ihm C-G, Lee GSL, Nast CC, et al. Early increased renal procollagen α(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 1992;41:768-77.
58. Engel J. Laminins and other strange proteins. Biochemistry 1992;31:10643-51.
59. Timpl R, Brown JC. The laminins. Matrix 1994;14:275-81.
60. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix 1994;14:209-11.
61. Engvall E. Laminin variants: Why, where and when. Kidney Int 1993;43:2-6.
62. Abrahamson DR, Irwin MH, St John PL, et al. Selective immunoreactivities of kidney basement membranes to monoclonal antibodies against laminin: Localization of the end of the long arm and the short arms to discrete microdomains. J Cell Biol 1989;109:3477-91.
63. Abrahamson DR, St John PL. Loss of laminin epitopes during glomerular basement membrane assembly in developing mouse kidneys. J Histochem Cytochem 1992;40:1943-53.
64. Abrahamson DR, St John PL. Laminin distribution in developing glomerular basement membranes. Kidney Int 1993:43:73-8.
65. Kootstra CJ, Bergijk EC, Veninga A, et al. Qualitative alterations in laminin expression in experimental lupus nephritis. Am J Pathol 1995;147:476-88.
66. Kootstra CJ, Abrahamson DR, de Heer E, et al. Differentiated expression of laminin epitopes during development of glomerulosclerosis in murine chronic graft verus host disease [abstract]. J Am Soc Nephrol 1994;5:811.
67. Abrass CK, Spicer D, Raugi GJ. Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture. Kidney Int 1994;46:613-20.
68. Ffrench-Constant C. Alternative splicing of fibronectin - many different proteins but a few different functions. Exp Cell Res 1995;221:261-71.
69. Bergijk EC, Baelde HJ, de Heer E, et al. Specific accumulation of exogenous fibronectin in experimental glomerulosclerosis. J Pathol 1995;176:191-99.
70. Meeritt SE, Killen PD, Phan SH, Wiggins RC. Analysis of α1 (1) procollagen and α1-(IV) collagen, and β-actin mRNA cortex of rabbits with experimental anti-glomerular basement membrane disease: Evidence for early extraglomerular collagen biosynthesis. Lab Invest 1990;63:762-9.
71. Wiggins R, Goyal M, Merritt S, Killen PD. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 1993;68:557-65.
72. Sady SP, Goyal M, Thomas PE, et al. Fibronectin mRNA in the developing glomerular crescent in rabbit antiglomerular basement membrane disease. J Am Soc Nephrol 1995;5: 2087-90.
73. Bergijk EC, Van Alderwegen IE, Sutmuller M, et al. N-desulfated heparinoids prevent the development of glomerulsclerosis in experimental lupus nephritis [abstract]. J Am Soc Nephrol 1995;6:892.
74. Van Alderwegen IE, Bergijk EC, Sutmuller M, et al. Glomerulosclerosis: Fibronectin does not accumulate in the glomerulus by binding via its heparin-binding sites [abstract]. J Am Soc Nephrol 1996;7:1767.
75. Rostagno AA, Frangione B, Gold L. Biochemical studies on the interaction of fibronectin with Ig. J Immunol 1991;146: 2687-93.
76. Bergijk EC, Baelde JJ, Kootstra CJ, et al. Cloning of the mouse fibronectin V-region and alteration of its splicing pattern in experimental immune-complex glomerulonephritis. J Pathol 1996;178:462-8.
77. Wilson CL, Schwarzbauer JE. The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots. J Cell Biol 1992;119:923-33.
78. Barnes JL, Mitchell RJ. Expression of the fibronectin isoform EIIIA parallels α-smooth muscle actin expression in anti-GBM nephritis [abstract]. J Am Soc Nephrol 1996;7:112P.
79. Alonso J, Gomez-Chiarri M, Ortiz A, et al. Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney Int 1996; 50:908-19.
80. Nickeleit V, Zagachin L, Nishikawa K, et al. Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am J Pathol 1995; 147:965-78.
81. Barnes JL, Torres ES, Mitchell RJ, Peters JH. Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol 1995;147: 1361-71.
82. Viedt C, Burger A, Hansch GM. Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. Kidney Int 1995; 48:1810-17.
83. Bergijk EC, Baelde HJ, de Heer E, Bruijn JA. Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus neprhitis. Kidney Int 1994;46:1663-73.
84. Doi T, Striker LJ, Kimata K, et al. Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 1991;173:1287-90.
85. Peten EP, Striker LJ, Carome MA, et al. The contribution of increased collagen synthesis to human glomerulosclerosis: A quantitative analysis of α2IV collagen mRNA expression by competitive polymerase chain reaction. J Exp Med 1992;176:1571-6.
86. Peten EP, Striker LJ, Garcia-Perez A, Striker GE. Studies by competitive PCR of glomerulosclerosis in growth hormone transgenic mice. Kidney Int 1993;43(suppl 39):S55-8.
87. Striker LJ. Modern renal biopsy interpretation: Can we predict glomerulosclerosis? Semin Nephrol 1993;13:508-15.
88. He C-J, Yang C-W, Peten EP, et al. Collagen and collagenase mRNAs in normal and sclerotic glomeruli: Predictors of progression and response to therapy. Kidney Int 1995; 47(suppl 49):S39-43.
89. Briggs JP, Todd KM, Schnermann J, Killen PD. Approach to the molecular basis of nephron heterogeneity: Application of reverse transcription - polymerase chain reaction to dissected tubule segments [abstract]. Semin Nephrol 1993; 13:2-12.
90. Singer PA, Theofilopoulos AN. T-cell receptor Vbeta repertoire expression in murine models of SLE. Immunol Rev 1990;118:103-27.
91. Harning R, Pelletier J, Van G, et al. Monoclonal antibody to MALA-2 (ICAM-1) reduces acute autoimmune nephritis in kdkd mice. Clin Immunol Immunopathol 1992;64:129-34.
92. Nishikawa K, Guo Y-J, Miyaseka M, et al. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 1993;177: 667-77.
93. Kawasaki K, Yaoita E, Yamamoto T, et al. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 1993;150:1074-83.
94. Duan L, Morrissey J, McCVracken R, Klahr S. Regulation of MCP-1, ICAM-1 and VCAM-1 during unilateral obstruction [abstract]. J Am Soc Nephrol 1996;7:112P.
95. Yamamoto T, Noble NA, Cohen AH, et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 1996;49:461-9.
96. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
97. Bruijn JA, Roos A, de Geus B, de Heer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 1994;123:34-47.
98. Kootstra CJ, Tijsma O, Baelde JJ, et al. TGFβ-independent development of glomerulosclerosis in murine chronic graft-versus-host disease (GVHD) [abstract]? J Am Soc Nephrol 1996; 7:1758.
99. Kootstra CJ, Nagelkerken L, Lemmers RJLF, et al. Evidence against a role for IL-6 in development of glomerulosclerosis in experimental lupus nephritis [abstract]. J Am Soc Nephrol 1994;5:755.
100. Wahl SM, Allen JB, Hines KL, et al. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 1994;94: 655-62.